AgingResearch.News
BMC Medicine

Risk-adapted intervals for colorectal cancer screening using fecal immunochemical tests: a modelling study based on the BLITZ cohort

By Thomas Heisser, Teresa Seum, Michael Hoffmeister, Hermann Brenner
Fig. 1. Expected detection rates of (A) colorectal cancer and (B) any advanced neoplasm at 1-5 years of follow-up by FIT-negative subgroup.
Open the figure at full size
Fig. 1. Expected detection rates of (A) colorectal cancer and (B) any advanced neoplasm at 1-5 years of follow-up by FIT-negative subgroup.Expected detection rates of (A) colorectal cancer and (B) any advanced neoplasm at 1-5 years of follow-up by FIT-negative subgroup.Heisser et al.
Computational studyBiomarkers

5 years, declared no competing interests

Paper

The paper

Thomas Heisser, Teresa Seum, Michael Hoffmeister, Hermann Brenner

German Cancer Research Center

BMC Medicine, 18 Aug 2026

doi.org/10.1186/s12916-026-05138-7PubMed 42613607

More on Modelling and theory